chrX-137030572-T-A
Variant summary
Our verdict is Likely benign. Variant got -1 ACMG points: 0P and 1B. BP4
The NM_054021.2(GPR101):c.1103A>T(p.Glu368Val) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000165 in 1,209,370 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 2 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. 13/19 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★).
Frequency
Consequence
NM_054021.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -1 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
GPR101 | NM_054021.2 | c.1103A>T | p.Glu368Val | missense_variant | 2/2 | ENST00000651716.2 | NP_473362.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
GPR101 | ENST00000651716.2 | c.1103A>T | p.Glu368Val | missense_variant | 2/2 | NM_054021.2 | ENSP00000498972.1 | |||
ENSG00000291054 | ENST00000693626.2 | n.394-29953T>A | intron_variant |
Frequencies
GnomAD3 genomes AF: 0.00000898 AC: 1AN: 111346Hom.: 0 Cov.: 22 AF XY: 0.0000298 AC XY: 1AN XY: 33512
GnomAD4 exome AF: 9.11e-7 AC: 1AN: 1098024Hom.: 0 Cov.: 32 AF XY: 0.00000275 AC XY: 1AN XY: 363388
GnomAD4 genome AF: 0.00000898 AC: 1AN: 111346Hom.: 0 Cov.: 22 AF XY: 0.0000298 AC XY: 1AN XY: 33512
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Dec 21, 2023 | The c.1103A>T (p.E368V) alteration is located in exon 1 (coding exon 1) of the GPR101 gene. This alteration results from a A to T substitution at nucleotide position 1103, causing the glutamic acid (E) at amino acid position 368 to be replaced by a valine (V). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
not provided Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 22, 2024 | This sequence change replaces glutamic acid, which is acidic and polar, with valine, which is neutral and non-polar, at codon 368 of the GPR101 protein (p.Glu368Val). This variant is not present in population databases (gnomAD no frequency). This variant has not been reported in the literature in individuals affected with GPR101-related conditions. An algorithm developed to predict the effect of missense changes on protein structure and function (PolyPhen-2) suggests that this variant is likely to be disruptive. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at